Research on HIV/AIDS in Children
2009
- New Dosing Recommendations Retrovir (Zidovudine) Syrup for HIV-Infected Infants (November 6, 2009)
From U.S. Food and Drug Administration
- Abused, Maltreated Kids Have Sex Earlier: Study (August 13, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Prechewed Infant Food May Transmit AIDS Virus (August 4, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV-Positive Babies More Likely to Contract Deadly TB if Given BCG (July 1, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Early HAART Initiation Improves Vaccine Response Among HIV-Positive Children, Study Says (May 1, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Home Stimulation Programme Shows Positive Impacts on the Neurodevelopmental Status of Children Infected With HIV (April 22, 2009)
From aidsmap.com
- Body-Shape Changes and Lipid Abnormalities Common in HIV-Positive Children and Young Adults (March 19, 2009)
From aidsmap.com
- Efforts to Help Children Affected by HIV/AIDS Should Focus on Families, Report Says (February 11, 2009)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Language Impairment May Be More Common Than Previously Thought in Perinatally HIV-Infected Children, Study Suggests (February 11, 2009)
One-third of 178 perinatally HIV-infected children scored low on language assessments in the 12-site prospective cohort study, explained Mabel Rice, Ph.D. There appeared to be a relationship between risk of secondary language impairment and any of three factors at study enrollment: CDC Class C; viral load >400 copies/mL; and CD4+ percentage <25%.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- 5% or More of Perinatally HIV-Infected Adolescents May Be Long-Term Nonprogressors, U.S. Study Suggests (February 10, 2009)
In what may be the first study of its kind, Rohan Hazra, M.D., offers data suggesting that a significant proportion of HIV-infected U.S. adolescents, all of whom were infected with HIV at birth, were able to remain off antiretroviral therapy for at least six months without experiencing any noticeable degree of disease progression.
In The 16th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- French Study Clears HAART of Cancer Link in Kids (February 2009)
To read PDF, click here
In Treatment Update, from Canadian AIDS Treatment Information Exchange
- Risk of Deformities Very Low in Infants Exposed to HAART (February 2009)
To read PDF, click here
In Treatment Update, from Canadian AIDS Treatment Information Exchange
2008
2007
2006
2005
2004
2003
- A Trial of a 9-Valent Pneumococcal Conjugate Vaccine in Children With and Those Without HIV Infection (November 2003)
[Archived Article]
Abstract of a study in the New England Journal of Medicine.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- HAART Use Higher Among "Responsible" HIV-Positive Youths (August 25, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- First-Time Sex for Teens Usually Not a "Casual Fling," Study Finds (August 11, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Higher Than Recommended Dose of Nevirapine Needed for HIV Suppression in Children (August 7, 2003)
[Archived Article]
From aidsmap.com
- Keys to Adherence in Youth: Simplicity, Knowledge, Support (August 7, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV Risk Higher for Rural Than for Urban/Suburban Adolescents, Particularly Among African Americans (August 4, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Senate Approves Bill Requiring Pediatric Testing of Drugs, Including HIV/AIDS Medications (July 25, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- HIV-Positive Teenagers With Lipodystrophy Have Lower Growth Hormone Secretion (July 1, 2003)
[Archived Article]
Researchers conducting a small study believe they've found the first link between lipodystrophy and lack of growth hormone in children on HAART.
From aidsmap.com
- Kids' Risk of HIV After Accidental Exposure Is Low (June 4, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- HIV-Positive Boys and Girls Enter Puberty Later (May 7, 2003)
[Archived Article]
A study finds children with low CD4 percentages start puberty half a year or more later than usual.
From aidsmap.com
- Youth and HIV: The Epidemic Continues (March 13, 2003)
[Archived Article]
An overview of research presented at the 2003 Retrovirus conference.
In The PRN Notebook
2002
1996-2001
- Protease Inhibitors in Children: Combination Therapy Reduced Death by Two Thirds (November 23, 2001)
[Archived Article]
To read PDF, click here
In AIDS Treatment News, from AIDS Treatment News
- Thinning Bones Found in HIV+ Girls (April 23, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange
- HAART-Associated Bone Mineral Loss Through Increased Rate of Bone Turnover in Vertically HIV-Infected Children (February 8, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- HIV-Infected Children on HAART Reconstitute Tetanus-Specific T Cell Responses Without Booster Vaccination (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Is Simplification of HAART Safe in HIV-Infected Children? First Pediatric Switch Study (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Mitochondrial and Mitochondrial-Like Symptoms in Children Born to HIV-Infected Mothers. Exhaustive Evaluation in a Large Prospective Cohort (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Virologic and Immunologic Responses in Children With Advanced HIV Disease on a New HAART Regimen (PACTG 366) (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Immunologic Reconstitution in Children and Adolescents Treated with HAART (February 6, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Pharmacologic Characteristics of Efavirenz and Nelfinavir Associated With Virologic Response in HIV-Infected Children (February 5, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Therapeutic Drug Monitoring of Amprenavir Combined With Ritonavir as Salvage Therapy in HIV-1-Infected Patients (July 11, 2000)
[Archived Article]
In The XIII International AIDS Conference, from The Body PRO
- Benefits and Barriers of Early Detection of HIV Infection Among Adolescents (July 7, 2000)
[Archived Article]
In SHOP Talk: School Health Opportunities and Progress Bulletin, from Sexuality Information and Education Council of the United States
- Early Therapy of Vertical HIV-1 Infection: Evidence for Cessation of Viral Replication and Absence of Virus-Specific Immunity (January 31, 2000)
[Archived Article]
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Immune Reconstitution and Viral Load Response in Antiretroviral-Naive Vertically HIV-Infected Children Enrolled in the PENTA 5 Trial (January 31, 2000)
[Archived Article]
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Response to Childhood Immunizations in HIV-Infected Children Treated With Potent Combination Antiretroviral Therapy (January 31, 2000)
[Archived Article]
In The 7th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Nucleoside Analogs Plus Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: A Randomized Controlled Trial (January 26, 2000)
[Archived Article]
In Journal of the American Medical Association
- Pediatric Study Group (Winter 1999/2000)
[Archived Article]
In Women's Treatment News, from PWA Health Group
- Triple-Drug Combination Pediatric Trial (Winter 1999/2000)
[Archived Article]
Do the results support our federal treatment guidelines?.
In Women's Treatment News, from PWA Health Group
- A Phase I Study of Hydroxyurea in HIV-Infected Children Receiving Didanosine and/or Stavudine (February 2, 1999)
[Archived Article]
In The 6th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Reassuring Findings About Infants Exposed to Zidovudine (January 12, 1999)
[Archived Article]
From U.S. National Institute of Allergy and Infectious Diseases
- Making Treatment Decisions in Children With HIV (October 1998)
[Archived Article]
In AIDS Care, from San Francisco General Hospital
- Study Shows Efavirenz Promising in Treating Pediatric HIV Infection (September 28, 1998)
[Archived Article]
Leads to approval of new drug for treating HIV-infected children.
From U.S. National Institute of Allergy and Infectious Diseases
- CD4 Count and Viral Load Do Predict Progression in Pediatric Patients (June 1998)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Advances in Pediatric HIV Research (Spring 1998)
[Archived Article]
In CRIA Update, from AIDS Community Research Initiative of America
- HIV Late Breakers I (September 28-October 1, 1997)
[Archived Article]
In The 37th Annual Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO
- Antiretroviral Therapy in Children (August 1997)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Combinations of Reverse Transcriptase Inhibitors in Children (August 1997)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Low-Dose ZDV Is Effective in Children (August 1997)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Triple Combination Therapy in Infants (August 1997)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Pediatric Trial of 141W94, Vertex Protease Inhibitor (July 18, 1997)
[Archived Article]
From AIDS Treatment News
- Major Pediatric Study Stopped Early: Combination Treatment Better (July 4, 1997)
[Archived Article]
From AIDS Treatment News
- ACTG 300 Leaves Many Questions Unanswered (July/August 1997)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Low-Dose ZDV Is Effective in Children (June 1996)
[Archived Article]
In HIV Newsline, from San Francisco General Hospital
- Pediatric Treatment Update (March 1996)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
|
|
Advertisement
|
E-Mail
Glossary
Share
